>>> US Gapping Up

Gapping up
In reaction to strong earnings/guidance
:
  • NTWK +11.8%, APOG +8.2%, STB +5.5%, LAKE +3.7%, GT +3.5%, (outlines growth plan, financial targets at Investor Day), JRJR +2.9%
Select EU financial related names showing strength: CS +2.3%, HSBC +1.5%, PUK +1.1%, DB +0.8%, SAN +0.5%

Select oil/gas related names showing strength: RIG +2.2%, WLL +1.6%, MRO +1.6%, SDRL +1.4%, BT +1.1%, YNDX+0.7%

Other news:
  • AERI +65.6% (reports its 12-month Phase 3 'Mercury 1' clinical trial for Roclatan achieved its primary efficacy endpoint)
  • ACRX +12.2% (Phase 3 trial (SAP303), ARX-04 was well tolerated in the management of moderate-to-severe acute pain in post-operative study patients )
  • ACTG +10% (favorable judgement against Apple in patent case)
  • DRYS +8.7% (DryShips agrees w/ Sifnos Shareholders to convert $8.75 mln of its revolver to 3.5 mln preferred shares)
  • CLSN +4% (announces the DSMB has completed its safety review of data from the first three patient cohorts in the ongoing Phase Ib OVATION Study)
  • JKS +2.5% (enters into a Master Module Supply Agreement with Con Edison Development)
  • TWTR +1.5% (continued strength)
  • CIE +1.3% (closed near lows after S&P lowered Cobalt International Energy Inc. unsolicited credit rating to 'CCC-' on possible restructuring; Outlook Negative)
Analyst comments:
  • ARNA +6.5% ( initiated with a Outperform at FBR & Co.; tgt $6)
  • BLUE +4.7% (added to Conviction Buy List at Goldman Sachs; tgt $135)
  • RIG +2% (upgraded to Hold from Sell at Canaccord Genuity)
  • GPN +1.4% (upgraded to Buy from Neutral at Goldman)
  • AAPL +1.3% (iPhone est raise at Credit Suisse)